Patient Awareness of CAR-T and Bispecific Antibody Treatments for Multiple Myeloma: Real-World Learnings and DisparitiesYaw Adu, Sikander Ailawadhi, Andre Fernandez et al.|Blood|2023Cited by 3
Survivorship Burden and Patient Preferences Affecting Treatment Choices Among Multiple Myeloma (MM) Patients: Real-World Learnings from a Large, Prospective StudyJayla Mondy, Sikander Ailawadhi, Yaw Adu et al.|Blood|2024Cited by 0
Predicting survivorship and caregiver burden in multiple myeloma (MM) using machine learning (ML): Insights from a large, national, prospective study.Saurav Das, Sikander Ailawadhi, Harshit Arora et al.|Journal of Clinical Oncology|2025Cited by 0